FAS and Alzheimer disease: Quantitative ELISA (Enzyme-linked Immunosorbent Assay) revealed increased levels of p53 and of another pro-apoptotic protein, APO-1/Fas (CD95), in several regions of cerebral cortex and cerebellum of DS patients with AD-like neuropathology comparing to healthy controls [61].